Voyager Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
VYGR Nasdaq 2834 www.voyagertherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Voyager Therapeutics, Inc.

Sector Update: Health Care Stocks Climb Late Afternoon - Jul 16th, 2025 2:08 pm
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach - Jul 16th, 2025 5:00 am
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - Jun 10th, 2025 5:00 am
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Jun 1st, 2025 4:05 am
With 46% ownership, Voyager Therapeutics, Inc. (NASDAQ:VYGR) has piqued the interest of institutional investors - May 20th, 2025 10:24 am
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication - May 15th, 2025 5:00 am
Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - May 6th, 2025 3:10 pm
Voyager Reports First Quarter 2025 Financial and Operating Results - May 6th, 2025 2:01 pm
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting - Apr 28th, 2025 2:30 pm
Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... - Apr 21st, 2025 2:33 pm
Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025 - Mar 31st, 2025 5:00 am
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates - Mar 11th, 2025 3:10 pm
Voyager Therapeutics: Q4 Earnings Snapshot - Mar 11th, 2025 2:25 pm
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - Mar 11th, 2025 2:01 pm
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast - Mar 4th, 2025 5:00 am
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach - Mar 4th, 2025 12:11 am
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease - Mar 3rd, 2025 5:00 am
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Feb 25th, 2025 5:00 am
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Feb 12th, 2025 6:01 am
Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025 - Feb 11th, 2025 8:19 am